Stability Indicating RP-HPLC Method for Simultaneous Determination of Atorvastatin and Amlodipine from Their Combination Drug Products
Open Access
- 1 January 2007
- journal article
- Published by Pharmaceutical Society of Japan in Chemical and Pharmaceutical Bulletin
- Vol. 55 (2) , 241-246
Abstract
The study describes development and subsequent validation of a stability indicating reverse-phase HPLC method for the simultaneous estimation of atorvastatin (ATV), and amlodipine (AML) from their combination drug product. The proposed RP-HPLC method utilizes a Lichrospher® 100 C18, 5 μm, 250 mm×4.0 mm i.d. column, at ambient temperature, optimum mobile phase consisted of acetonitrile and 50 mM potassium dihdrogen phosphate buffer (60 : 40, v/v), apparent pH adjusted to 3±0.1 with 10% phosphoric acid solution, effluent flow rate monitored at 1.0 ml/min, and UV detection at 254 nm. ATV, AML, and their combination drug product were exposed to thermal, photolytic, hydrolytic, and oxidative stress conditions, and the stressed samples were analyzed by proposed method. The method was applied for the in vitro dissolution of marketed combination drug products. The described method was linear over the range of 1—90 μg/ml and 1—80 μg/ml for ATV and AML, respectively. The mean recoveries were 99.76 and 98.12% for ATV and AML, respectively. The intermediate precision data obtained under different experimental setup, the calculated value of coefficient of variation (CV, %) was found to be less than critical value. The limit of detection for ATV and AML were found to be 0.4 and 0.6 μg/ml, respectively and the limit of quantification was 1.0 μg/ml for both drugs. The average percentage drug release was found to be more than 70% within 30 min for both drugs. Chromatographic peak purity data of ATV and AML indicated no co-eluting peaks with the main peaks of drugs which demonstrated the specificity of assay method for their estimation in presence of degradation products. The proposed method can be useful in the quality control and in vitro dissolution of combination drug products.Keywords
This publication has 11 references indexed in Scilit:
- Determination of atorvastatin in human serum by reversed-phase high-performance liquid chromatography with UV detectionJournal of Chromatography B, 2005
- Analysis of five HMG‐CoA reductase inhibitors— atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studiesBiomedical Chromatography, 2005
- Stability indicating RP-HPLC method for simultaneous determination of amlodipine and benazepril hydrochloride from their combination drug productJournal of Pharmaceutical and Biomedical Analysis, 2005
- Determination of atorvastatin and metabolites in human plasma with solid-phase extraction followed by LC–tandem MSAnalytical and Bioanalytical Chemistry, 2005
- An HPLC method for the determination of atorvastatin and its impurities in bulk drug and tabletsJournal of Pharmaceutical and Biomedical Analysis, 2003
- Enantiomeric determination of amlodipine in human plasma by liquid chromatography coupled to tandem mass spectrometryJournal of Biochemical and Biophysical Methods, 2002
- Amlodipine bioequivalence study: quantification by liquid chromatography coupled to tandem mass spectrometryBiopharmaceutics & Drug Disposition, 2001
- Quantitation of the acid and lactone forms of atorvastatin and its biotransformation products in human serum by high-performance liquid chromatography with electrospray tandem mass spectrometryRapid Communications in Mass Spectrometry, 1999
- Development and validation of a high-performance liquid chromatography tandem mass spectrometry assay for atorvastatin, ortho-hydroxy atorvastatin, and para-hydroxy atorvastatin in human, dog, and rat plasmaJournal of the American Society for Mass Spectrometry, 1999
- Detection and determination of total amlodipine by high-performance thin-layer chromatography: a useful technique for pharmacokinetic studiesJournal of Chromatography B: Biomedical Sciences and Applications, 1995